1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22114
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIoannidis, J. P.en
dc.contributor.authorRosenberg, P. S.en
dc.contributor.authorGoedert, J. J.en
dc.contributor.authorAshton, L. J.en
dc.contributor.authorBenfield, T. L.en
dc.contributor.authorBuchbinder, S. P.en
dc.contributor.authorCoutinho, R. A.en
dc.contributor.authorEugen-Olsen, J.en
dc.contributor.authorGallart, T.en
dc.contributor.authorKatzenstein, T. L.en
dc.contributor.authorKostrikis, L. G.en
dc.contributor.authorKuipers, H.en
dc.contributor.authorLouie, L. G.en
dc.contributor.authorMallal, S. A.en
dc.contributor.authorMargolick, J. B.en
dc.contributor.authorMartinez, O. P.en
dc.contributor.authorMeyer, L.en
dc.contributor.authorMichael, N. L.en
dc.contributor.authorOperskalski, E.en
dc.contributor.authorPantaleo, G.en
dc.contributor.authorRizzardi, G. P.en
dc.contributor.authorSchuitemaker, H.en
dc.contributor.authorSheppard, H. W.en
dc.contributor.authorStewart, G. J.en
dc.contributor.authorTheodorou, I. D.en
dc.contributor.authorUllum, H.en
dc.contributor.authorVicenzi, E.en
dc.contributor.authorVlahov, D.en
dc.contributor.authorWilkinson, D.en
dc.contributor.authorWorkman, C.en
dc.contributor.authorZagury, J. F.en
dc.contributor.authorO'Brien, T. R.en
dc.date.accessioned2015-11-24T19:21:38Z-
dc.date.available2015-11-24T19:21:38Z-
dc.identifier.issn0003-4819-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22114-
dc.rightsDefault Licence-
dc.subjectAcquired Immunodeficiency Syndrome/genetics/mortalityen
dc.subjectAllelesen
dc.subjectChemokine CXCL12en
dc.subjectChemokines, CXC/*geneticsen
dc.subjectDisease Progressionen
dc.subjectHIV Infections/*geneticsen
dc.subject*HIV-1/geneticsen
dc.subjectHeterozygoteen
dc.subjectHumansen
dc.subjectProportional Hazards Modelsen
dc.subjectRNA/metabolismen
dc.subjectReceptors, CCR2en
dc.subjectReceptors, CCR5/*geneticsen
dc.subjectReceptors, Chemokine/*geneticsen
dc.subjectRegression Analysisen
dc.titleEffects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient dataen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/11694103-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2001-
heal.abstractBACKGROUND: Studies relating certain chemokine and chemokine receptor gene alleles with the outcome of HIV-1 infection have yielded inconsistent results. OBJECTIVE: To examine postulated associations of genetic alleles with HIV-1 disease progression. DESIGN: Meta-analysis of individual-patient data. SETTING: 19 prospective cohort studies and case-control studies from the United States, Europe, and Australia. PATIENTS: Patients with HIV-1 infection who were of European or African descent. MEASUREMENTS: Time to AIDS, death, and death after AIDS and HIV-1 RNA level at study entry or soon after seroconversion. Data were combined with fixed-effects and random-effects models. RESULTS: Both the CCR5-Delta32 and CCR2-64I alleles were associated with a decreased risk for progression to AIDS (relative hazard among seroconverters, 0.74 and 0.76, respectively; P = 0.01 for both), a decreased risk for death (relative hazard among seroconverters, 0.64 and 0.74; P < 0.05 for both), and lower HIV-1 RNA levels after seroconversion (difference, -0.18 log(10) copies/mL and -0.14 log(10) copies/mL; P < 0.05 for both). Having the CCR5-Delta32 or CCR2-64I allele had no clear protective effect on the risk for death after development of AIDS. The results were consistent between seroconverters and seroprevalent patients. In contrast, SDF-1 3'A homozygotes showed no decreased risk for AIDS (relative hazard for seroconverters and seroprevalent patients, 0.99 and 1.03, respectively), death (relative hazard, 0.97 and 1.00), or death after development of AIDS (relative hazard, 0.81 and 0.97; P > 0.5 for all). CONCLUSIONS: The CCR5-Delta32 and CCR2-64I alleles had a strong protective effect on progression of HIV-1 infection, but SDF-1 3'A homozygosity carried no such protection.en
heal.journalNameAnn Intern Meden
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
There are no files associated with this item.
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons